Your Article Summary
See Latest ArticlesReduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT
Bone Marrow Transplantation, 06/23/09
Cable C et al. - Rapid attainment of full donor chimerism after flu/TBI is associated with greater survival than after flu/ATG/BU. Further, larger prospective randomized studies are required to define the advantage of one regimen over the other.
Related Articles
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
Bone Marrow Transplantation, 12/03/09
Relevance Score: 67%%
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09
Relevance Score: 67%%
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation, 11/19/09
Relevance Score: 65%%
Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Biology of Blood and Marrow Transplantation, 11/19/09
Relevance Score: 65%%
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT
Bone Marrow Transplantation, 11/19/09
Relevance Score: 65%%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Factors Predicting Long Term Survival After T Cell Depleted Reduced Intensity Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Haematologica, 12/09/09
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09
Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management
Expert Review of Dermatology, 12/03/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Ipilimumab monotherapy in patients with pretreated advanced melanoma: A randomised, double-blind, multicentre, phase 2, dose-ranging study
The Lancet Oncology - Online First, 12/09/09
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤ 1 cm) invasive breast cancer: Who might be possible candidates for adjuvant treatment?
Breast Cancer Research and Treatment, 12/09/09